Gastrointestinal symptom prevalence depends on disease duration and gastrointestinal region in type 2 diabetes mellitus

Figure 4 Relationships between various medications, which demonstrated significance as shown in Figure 3, and diabetes duration in terms of the presence of related gastrointestinal symptoms. White bars show the percentages of subjects with a score of 5 or higher for the indicated GI symptoms (A: Constipation, B: Diarrhea) without use of the indicated medications. Numbers under each bar within brackets are the number of patients not using the indicated medications. DPP-4i: Dipeptidyl-peptidase 4 inhibitor; GI: Gastrointestinal.